Alphamab Oncology (HK:9966)
:9966
Want to see HK:9966 full AI Analyst Report?
Comparison Results
Alphamab Oncology
HK$11.90
HK$8.33B
-15.87
12.35%
1 Buy
0 Hold
0 Sell
Moderate Buy
RemeGen Co. Ltd. Class H
HK$119.90
HK$65.25B
36.25
82.55%
8 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$27.54
HK$39.90B
-256.36
47.70%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$10.20B
-75.25
-15.24%
1 Buy
0 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$5.34
HK$12.15B
-15.04
126.47%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$84.45
HK$38.67B
―
75.46%
6 Buy
0 Hold
0 Sell
Strong Buy
Performance Comparison
HK:9966
Alphamab Oncology
8.55
-0.43
-4.79%
HK:9995
RemeGen Co. Ltd. Class H
85.80
38.90
82.94%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
23.16
6.22
36.72%
HK:2171
CARsgen Therapeutics Holdings Ltd.
17.63
-3.97
-18.38%
HK:2616
CStone Pharmaceuticals
7.70
4.04
110.38%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
71.15
27.65
63.56%